C. Savage

发表

Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.

C. Pusey, A. Rees, G. Gaskin, 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.

C. Savage, C. Savage, L. Harper, 2005, Rheumatology.

Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation

W. Zuercher, A. Meijer, C. Savage, 2019, bioRxiv.

Can neutrophils be manipulated in vivo?

C. Savage, X. Lu, L. Harper, 2005, Rheumatology.

Leukocyte-endothelial interactions in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

C. Savage, L. Harper, Caroline O. S. Savage, 2001, Rheumatic diseases clinics of North America.

Pathogenesis of ANCA‐associated systemic vasculitis

C. Savage, C. Savage, L. Harper, 2000, The Journal of pathology.

Case of propylthiouracil-induced ANCA associated small vessel vasculitis.

P. Cockwell, C. Savage, L. Harper, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

ANCA-associated renal vasculitis.

C. Savage, 2001, Kidney international.

Primary systemic vasculitis

D. Adu, C. Savage, C. Savage, 1997, The Lancet.

Anti-endothelial cell antibodies from lupus patients bind to apoptotic endothelial cells promoting macrophage phagocytosis but do not induce apoptosis.

J. Williams, C. Savage, L. Harper, 2005, Rheumatology.

Malignancy is increased in ANCA-associated vasculitis.

C. Gordon, C. Savage, L. Harper, 2004, Rheumatology.

Treatment of IgA nephropathy

C. Savage, L. Harper, 1999, The Lancet.

Mechanisms of acute renal failure.

C. Savage, L. Harper, Caroline O. S. Savage, 1996, British journal of anaesthesia.

Resident glomerular cells in glomerular injury: endothelial cells.

C. Savage, R. Bogle, 1991, Seminars in nephrology.

Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

J. Pearson, C. Pusey, G. Gaskin, 1992, The American journal of pathology.

ANCA-associated vasculitis is linked to carriage of the Z allele of α1 antitrypsin and its polymers

R. Stockley, D. Lomas, A. McKnight, 2011, Annals of the rheumatic diseases.

Mannose-binding lectin gene polymorphisms in a cohort study of ANCA-associated small vessel vasculitis.

J. Heward, S. Gough, J. Williams, 2007, Rheumatology.

IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis.

J. Williams, C. Savage, C. Savage, 2006, Kidney international.

Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity.

C. Pusey, G. Gaskin, C. Savage, 1993, Advances in experimental medicine and biology.

Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti‐endothelial cell antibodies and their relation to anti‐neutrophil cytoplasm antibodies

J. Pearson, C. Pusey, C. Savage, 1991, Clinical and experimental immunology.

The role of the endothelium in systemic vasculitis.

C. Savage, S. P. Cooke, 1993, Journal of autoimmunity.

Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.

C. Pusey, G. Gaskin, C. Savage, 1993, Experimental nephrology.

Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils.

S. Nuttall, C. Savage, L. Harper, 2002, Rheumatology.

The endothelial cell:active participant or innocent bystander in primary vasculitis?

C. Savage, 1993, Clinical and experimental immunology.

Anti-heparin antibodies: part of the repertoire of anti-endothelial cell antibodies (AECA)

C. Savage, L. Harper, 1998, Lupus.

Translational research in autoimmunity: aims of therapy in vasculitis.

D. Scott, J. Williams, J. Levy, 2005, Rheumatology.

ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process

A. Challa, J. Williams, J. Gordon, 2011, Annals of the rheumatic diseases.

Mechanisms of endothelial injury in systemic vasculitis.

C. Savage, L. Harper, 1999, Advances in nephrology from the Necker Hospital.

ABC of arterial and vascular disease: vasculitis.

A. Howie, P. Cockwell, C. Savage, 2000, BMJ.

Propylthiouracil and carbimazole associated‐antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves’ disease

J. Franklyn, J. Heward, S. Gough, 2004, Clinical endocrinology.

The biology of the glomerulus: endothelial cells.

C. Savage, C. O. S. Savage, 1994, Kidney international.

Impairment of lung function, health status and functional capacity in patients with ANCA-associated vasculitis.

C. Savage, L. Harper, S. Schinke, 2005, Rheumatology.

Primary systemic vasculitis.

C. Savage, C. Day, 2001, Minerva medica.

Meta‐analysis of myeloperoxidase G‐463/A polymorphism in anti‐neutrophil cytoplasmic autoantibody‐positive vasculitis

D. Adu, C. Savage, C. Savage, 2007, Clinical and experimental immunology.

The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis.

J. Williams, C. Savage, L. Harper, 2004, Biochemical Society transactions.